About
Densitas Inc. is a leader in artificial intelligence solutions for breast cancer screening, specializing in digital mammography products tailored for hospitals and radiology clinics. The company develops AI-driven software platforms that analyze mammography images to enhance breast cancer detection and improve screening quality. One of Densitas' key products is DM-Density, which automates breast density scoring, an important factor in assessing cancer risk. This product has received regulatory approvals, including the CE Mark and a medical device license from Health Canada, with FDA clearance in progress. The intelliMammo® Platform is another core offering, featuring AI modules that provide rapid results and support quality control in mammography. This web-based platform integrates with existing clinical systems and offers tools for performance tracking and automated reporting. Densitas collaborates with other healthcare technology companies to further enhance breast health care. Its solutions are designed for hospitals, radiology clinics, and breast imaging centers, aiming to improve screening accuracy and operational efficiency while ensuring compliance with quality standards.
Technologies
Keywords
Company Information
-
Employees 32
-
Founded 2011
-
Total Funding $250000
Location
1344 Summer St, Halifax, Nova Scotia, Canada, B3H 0A8
